Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$224.03 -3.25 (-1.43%)
At close: Oct 23, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

Alnylam Pharmaceuticals (ALNY) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Alnylam Pharmaceuticals 29.96 Bn 18.01 Bn 992.69 Mn 290.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 290.70 Mn
Mar 31, 2026 262.02 Mn
Dec 31, 2025 222.04 Mn
Sep 30, 2025 725.07 Mn
Jun 30, 2025 341.72 Mn
Mar 31, 2025 573.21 Mn
Dec 31, 2024 443.01 Mn
Sep 30, 2024 423.52 Mn
Jun 30, 2024 357.57 Mn
Mar 31, 2024 405.44 Mn
Dec 31, 2023 363.81 Mn
Sep 30, 2023 432.22 Mn
Jun 30, 2023 393.60 Mn
Mar 31, 2023 422.65 Mn
Dec 31, 2022 604.72 Mn
Sep 30, 2022 558.44 Mn
Jun 30, 2022 643.74 Mn
Mar 31, 2022 514.62 Mn
Dec 31, 2021 307.45 Mn
Sep 30, 2021 422.10 Mn
API Access

Alnylam Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALNY&period=max&api_key=YOUR_API_KEY